Dyne Therapeutics, Inc. — Form 4
Filed July 8, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 59/100
What the filing says
Director Rhodes Jason P (DYN) sold 777K shares (~$17.9M) on the open market (100% of holdings). Large sale — ~100% of holdings.
Why this rating
Large sale — ~100% of holdings.
See more from July 8, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.